Autologous bone marrow mononuclear cell infusion for liver cirrhosis after the Kasai operation in children with biliary atresia

AIM: To evaluate the safety and early outcomes of autologous bone marrow mononuclear cell (BMMNC) infusion for liver cirrhosis due to biliary atresia (BA) after Kasai operation. METHODS: An open-label clinical trial was performed from January 2017 to December 2019. Nineteen children with liver cirrh...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thanh Liem, Nguyen, Hoang Phuong, Ngo, Duy Minh, Ha, Thu Hien Thi, Mai, Kieu - Anh, Bui, Thu Hang, Nguyen, Phan Van, Pham, Lan Huong, Hoang, Duc Minh, Cao, Anh Dao Thi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919575/
https://www.ncbi.nlm.nih.gov/pubmed/35287722
http://dx.doi.org/10.1186/s13287-022-02762-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919575/
https://www.ncbi.nlm.nih.gov/pubmed/35287722
http://dx.doi.org/10.1186/s13287-022-02762-x

Ejemplares similares